Skip to Content

Erlotinib

In the US, Erlotinib (erlotinib systemic) is a member of the drug class EGFR inhibitors and is used to treat Non-Small Cell Lung Cancer, Pancreatic Cancer and Renal Cell Carcinoma.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XE03

CAS registry number (Chemical Abstracts Service)

0183321-74-6

Chemical Formula

C22-H23-N3-O4

Molecular Weight

393

Therapeutic Category

Cytostatic agent: Epidermal growth factor receptor tyrosine kinase inhibitor

Chemical Names

4-Quinazolinamine, N-(3-etynylphenyl)-6,7-bis(2-metoxyetoxy)-,

N-(3-etynylphenyl)-6,7-bis(2-metoxyetoxy)chinazolin-4-amin (IUPAC)

N-(3-etynylphenyl)-6,7-bis(2-metoxyetoxy)quinazolin-4-amine (WHO)

Foreign Names

  • Erlotinibum (Latin)
  • Erlotinib (German)
  • Erlotinib (French)
  • Erlotinib (Spanish)

Generic Names

  • Erlotinib (OS: BAN)
  • Erlotinib Hydrochloride (OS: USAN, BANM, JAN)
  • CP-358,774-01 (IS)
  • NSC 718781 (IS)
  • OSI-774 (IS: Osi)
  • R-1415 (IS)

Brand Names

  • Erleva
    Glenmark, India
  • Tarcenib
    Techno, Bangladesh
  • Tarceva
    Roche, Colombia; Roche, Georgia; Roche, Hong Kong; Roche, Israel; Roche, Lebanon; Roche, Philippines; Roche, Turkey; Roche, Vietnam; Chugai Pharmaceutical, Japan; F. Hoffmann-La Roche LTD, Serbia; Genentech, United States; Haemato Pharm, Austria; Hoffmann-La Roche, Bosnia & Herzegowina; Productos Roche, Chile; Roche, Armenia; Roche, Argentina; Roche, Australia; Roche, Belgium; Roche, Canada; Roche, China; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Ecuador; Roche, Egypt; Roche, Spain; Roche, Finland; Roche, France; Roche, Greece; Roche, Croatia (Hrvatska); Roche, Hungary; Roche, Indonesia; Roche, Ireland; Roche, Iceland; Roche, Italy; Roche, Moldova; Roche, Myanmar; Roche, Mexico; Roche, Netherlands; Roche, Norway; Roche, New Zealand; Roche, Oman; Roche, Poland; Roche, Portugal; Roche, Romania; Roche, Sweden; Roche, Thailand; Roche, Taiwan; Roche, Uruguay; Roche, South Africa; Roche Products, United Kingdom; Roche Registration, Austria; Roche, Lithuania

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide